Correlation Between NYSE Composite and Organogenesis Holdings
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Organogenesis Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Organogenesis Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Organogenesis Holdings, you can compare the effects of market volatilities on NYSE Composite and Organogenesis Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Organogenesis Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Organogenesis Holdings.
Diversification Opportunities for NYSE Composite and Organogenesis Holdings
0.75 | Correlation Coefficient |
Poor diversification
The 3 months correlation between NYSE and Organogenesis is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Organogenesis Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Organogenesis Holdings and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Organogenesis Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Organogenesis Holdings has no effect on the direction of NYSE Composite i.e., NYSE Composite and Organogenesis Holdings go up and down completely randomly.
Pair Corralation between NYSE Composite and Organogenesis Holdings
Assuming the 90 days trading horizon NYSE Composite is expected to generate 4.26 times less return on investment than Organogenesis Holdings. But when comparing it to its historical volatility, NYSE Composite is 5.52 times less risky than Organogenesis Holdings. It trades about 0.21 of its potential returns per unit of risk. Organogenesis Holdings is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest 334.00 in Organogenesis Holdings on November 18, 2024 and sell it today you would earn a total of 36.00 from holding Organogenesis Holdings or generate 10.78% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
NYSE Composite vs. Organogenesis Holdings
Performance |
| Timeline |
NYSE Composite and Organogenesis Holdings Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Organogenesis Holdings
Pair trading matchups for Organogenesis Holdings
Pair Trading with NYSE Composite and Organogenesis Holdings
The main advantage of trading using opposite NYSE Composite and Organogenesis Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Organogenesis Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organogenesis Holdings will offset losses from the drop in Organogenesis Holdings' long position.| NYSE Composite vs. Zhihu Inc ADR | NYSE Composite vs. Allied Gaming Entertainment | NYSE Composite vs. Asure Software | NYSE Composite vs. SohuCom |
| Organogenesis Holdings vs. Shuttle Pharmaceuticals | Organogenesis Holdings vs. Lifecore Biomedical | Organogenesis Holdings vs. Redhill Biopharma | Organogenesis Holdings vs. Collegium Pharmaceutical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |